Suzuki I, Yoshida S, Tabu K, Kusunoki S, Matsumura Y, Izumi H, Asanoma K, Yagi H, Onoyama I, Sonoda K, Kohno K, Taga T, Takeda S, Kato K. YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer Scientific Reports. 2021.02; 11 (1): 4220.

Taga T and Tabu K. Glioma progression and recurrence involving maintenance and expansion strategies of glioma stem cells by organizing self-advantageous niche microenvironments. Inflammation and Regeneration. 2020.09; 40 33. ( DOI )

Tabu K, Liu W, Kosaku A, Terashima K, Murota Y, Aimaitijiang A, Nobuhisa I, Hide T, Taga T. Glioma stem cell (GSC)-derived autoschizis-like products confer GSC niche properties involving M1-like tumor-associated macrophages. Stem cells (Dayton, Ohio). 2020.08; 38 (8): 921-935. ( PubMed, DOI )

Tabu K, Muramatsu N, Mangani C, Wu M, Zhang R, Kimura T, Terashima K, Bizen N, Kimura R, Wang W, Murota Y, Kokubu Y, Nobuhisa I, Kagawa T, Kitabayashi I, Bradley M, and Taga T. A synthetic polymer scaffold reveals the self-maintenance strategies of rat glioma stem cells by organization of the advantageous niche. Stem Cells. 2016.05; 34 1151-1162. ( DOI )

Kokubu Y, Tabu K, Wang W, Muramatsu N, Murota Y, Nobuhisa I, Jinushi M, and Taga T. Induction of protumoral CD11c^high macrophages by glioma cancer stem cells through GM-CSF. Genes to Cells. 2016.03; 21 241-251. ( DOI )

Inagaki T, Kusunoki S, Tabu K, Okabe H, Yamada I, Taga T, Matsumoto A, Makino S, Takeda S, Kato K.. Up-regulation of lymphocyte antigen 6 complex expression in side-population cells derived from a human trophoblast cell line HTR-8/SVneo. Hum Cell. 2016.01; 29 10-21.

Bizen N, Inoue T, Shimizu T, Tabu K, Kagawa T, Taga T. A growth-promoting signaling component cyclin D1 in neural stem cells has antiastrogliogenic function to execute self-renewal. Stem cells (Dayton, Ohio). 2014.06; 32 (6): 1602-15. ( PubMed, DOI )

Kusunoki S, Kato K, Tabu K, Inagaki T, Okabe H, Kaneda H, Suga S, Terao Y, Taga T, Takeda S. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells. Gynecologic oncology. 2013.06; 129 (3): 598-605. ( PubMed, DOI )

Tabu K, Bizen N, Taga T, Tanaka S. Gene Regulation of Prominin-1 (CD133) in Normal and Cancerous Tissues. Advances in experimental medicine and biology. 2013; 777 73-85. ( PubMed, DOI )

Kimura T, Wang L, Tabu K, Nishihara H, Mashita Y, Kikuchi N, Tanino M, Hiraga H, Tanaka S. CD133 negatively regulates tumorigenicity via AKT pathway in synovial sarcoma. Cancer investigation. 2012.06; 30 (5): 390-7. ( PubMed, DOI )

Tanino M, Kohsaka S, Kimura T, Tabu K, Nishihara H, Sawa H, Kawami H, Kamada H, Shimizu M, Tanaka S. A case of clear cell variant of solid-pseudopapillary tumor of the pancreas in an adult male patient. Annals of diagnostic pathology. 2012.04; 16 (2): 134-40. ( PubMed, DOI )

Tabu K, Kimura T, Sasai K, Wang L, Bizen N, Nishihara H, Taga T, Tanaka S. Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks. Molecular cancer. 2010.02; 9 39. ( PubMed, DOI )

Kimura T, Sakai M, Tabu K, Wang L, Tsunematsu R, Tsuda M, Sawa H, Nagashima K, Nishihara H, Hatakeyama S, Nakayama K, Ladanyi M, Tanaka S, Nakayama KI. Human synovial sarcoma proto-oncogene Syt is essential for early embryonic development through the regulation of cell migration. Laboratory investigation; a journal of technical methods and pathology. 2009.06; 89 (6): 645-56. ( PubMed, DOI )

Tabu K, Sasai K, Kimura T, Wang L, Aoyanagi E, Kohsaka S, Tanino M, Nishihara H, Tanaka S. Promoter hypomethylation regulates CD133 expression in human gliomas. Cell research. 2008.10; 18 (10): 1037-46. ( PubMed, DOI )

Nishihara H, Ozaki Y, Ito T, Yoshinaga T, Tabu K, Tanino M, Nagashima K, Tanaka S. A case of cerebral ganglioneuronal tumor in the parietal lobe of an adult. Brain tumor pathology. 2008.04; 25 (1): 45-9. ( PubMed, DOI )

Wang L, Tabu K, Kimura T, Tsuda M, Linghu H, Tanino M, Kaneko S, Nishihara H, Tanaka S. Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4. Biochemical and biophysical research communications. 2007.11; 362 (4): 976-81. ( PubMed, DOI )

Tabu K, Ohba Y, Suzuki T, Makino Y, Kimura T, Ohnishi A, Sakai M, Watanabe T, Tanaka S, Sawa H. Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA. Molecular cancer research : MCR. 2007.10; 5 (10): 1099-109. ( PubMed, DOI )

Sasai K, Akagi T, Aoyanagi E, Tabu K, Kaneko S, Tanaka S. O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies. Molecular cancer. 2007.06; 6 36. ( PubMed, DOI )

Tabu K, Ohnishi A, Sunden Y, Suzuki T, Tsuda M, Tanaka S, Sakai T, Nagashima K, Sawa H. A novel function of OLIG2 to suppress human glial tumor cell growth via p27Kip1 transactivation. Journal of cell science. 2006.04; 119 (Pt 7): 1433-41. ( PubMed, DOI )

Asanuma T, Inanami O, Tabu K, Waki K, Kon Y, Kuwabara M. Protection against malonate-induced ischemic brain injury in rat by a cell-permeable peptidic c-Jun N-terminal kinase inhibitor, (L)-HIV-TAT48-57-PP-JBD20, observed by the apparent diffusion coefficient mapping magnetic resonance imaging method. Neuroscience letters. 2004.04; 359 (1-2): 57-60. ( PubMed, DOI )

Yoshitaka Murota, Kouichi Tabu, Tetsuya Taga. Establishment of a high-content polymer array screening system to explore niche mimicries for cancerous cells. The 17th International Symposium of the Institute Network for Biomedical Science International Symposium on Tumor Biology in Kanazawa 2022 2022.10.14 Cancer Research Institute of Kanazawa University, Kanazawa, Japan

Kouichi Tabu, Shinji Kohsaka, Takuichiro Hide, Tetsuya Taga. Synthetic polymer microenvironment array chip based development of new cell phenomics for cancer stratification. The 81st Annual Meeting of the Japanese Cancer Association 2022.10.01 Pacifico Yokohama, Yokohama, Japan

Tingting Zhang, Kouichi Tabuk, Yoshitaka Murota, Takuichiro Hide, Shunichiro Ogura, Tetsuya Taga. Exploration of glioma recurrence-related genes upregulated in highly invasive and 5-ALA-PDD escaping cells. The 81st Annual Meeting of the Japanese Cancer Association 2022.09.30 Pacifico Yokohama, Yokohama, Japan

Yoshitaka Murota, Kouichi Tabu, Tetsuya Taga. Establishment of a high-content screening system for niche mimicries using polymer-immobilized microwell array plates. The 81st Annual Meeting of the Japanese Cancer Association 2022.09.30 Pacifico Yokohama, Yokohama, Japan

Tetsuya Taga, Norihisa Bizen, Kouichi Tabu, Mei Wu, Christian Mangani, Rong Zhang, Mark Bradley. Identification of a niche-mimicking synthetic polymer scaffold that maintains neural stem cells in a growth factor- and serum-free system. The 19 th Stem Cell Research Symposium 2022.05.27 Awaji Yumebutai International Conference Center, Awaji, Japan

Kouichi Tabu and Tetsuya Taga. Cancer stem cell niche-mimicking polymer-based exploration of the factors responsible for glioma recurrence. The 80th Annual Meeting of the Japanese Cancer Association 2021.10.01 PACIFICO Yokohama, Yokohama, Japan

Kouichi Tabu, Tetsuya Taga. Polymer-based elucidation of molecular basis underlying cancer stem cell-mediated niche reconstruction and glioma recurrence. The 18th Stem Cell Research Symposium 2021.05.21

Mariko Nagane, Kouichi Tabu, Yoshitaka Murota, Shinji Tanaka, Tetsuya Taga. Niche-mimicking polymer-based characterization of human pancreatic cancer stem cells (pCSCs). The 18th Stem Cell Research Symposium 2021.05.21

Tabu K, Zhang S, Kosaku A, Venkateswaran S, Kohsaka S, Bradley M, Taga T . Synthetic polymer-based stratification of soft tissue sarcomas with different gene alterations and cells of origin. 11th World Biomaterials Congress (WBC Virtual 2020) 2020.12.11

Nagane M, Tabu K, Murota Y, Tanaka S, Taga T. Fabrication of niche-mimicking polymer hydrogels to characterize human pancreatic cancer stem cells. The 43rd Annual Meeting of the Molecular Biology Society of Japan 2020.12.02

Tabu K and Taga T. Chemical fabrication of bio-functional polymer-hydrogels that mimic cancer stem cell niche. The 79th Annual Meeting of the Japanese Cancer Association 2020.10.01

Kosaku A, Tabu K, Kohsaka S, Taga T . A new stratification method for predicting chemosensitivities of soft tissue sarcomas using synthetic polymer microarray. The 79th Annual Meeting of the Japanese Cancer Association 2020.10.01

Aimaitijiang A, Tabu K, Wang W, Nobuhisa I, Taga T. Glioma stem cells promote erythroid differentiation in mouse bone marrow. The 41st Annual Meeting of the Japanese Society of Inflammation and Regeneration 2020.07.08

Tabu K, Wenyu L and Taga T. A self-expanding strategy of glioma stem cells via promoting the development of M1-like tumor-associated macrophages. . The 42nd Annual Meeting of the Molecular Biology Society of Japan 2019.12.04 Fukuoka Convention Center, Fukuoka, Japan

Tabu K and Taga T. Visualization and validation of monocyte-recruiting cells as a potential target of glioma stem cells. The 78th Annual Meeting of the Japanese Cancer Association 2019.09.28 Kyoto, Japan

Aimaitijiang A, Tabu K and Taga. Glioma stem cells modulate erythropoiesis in mouse bone marrow. The 78th Annual Meeting of the Japanese Cancer Association 2019.09.28 Kyoto, Japan

Tabu K and Taga T. Visualization and validation of monocyte-recruiting cells as a potential target of glioma stem cells. The 78th Annual Meeting of the Japanese Cancer Association 2019.09.28 Kyoto, Japan

Aimaitijiang A, Tabu K and Taga T. Glioma stem cells modulate erythropoiesis in mouse bone marrow. The 78th Annual Meeting of the Japanese Cancer Association 2019.09.28 Kyoto, Japan

Taga T and Tabu K. Exploration of molecular mechanisms regulating cancer stem cells and their niche. International Summer Program (ISP) 2019 2019.07.09 TMDU, Bunkyo-ku, Japan

Taga T and Tabu K. Development of Treatment Strategies Targeting Cancer Stem Cells. The 3rd Meeting of International Society of Precision Cancer Medicine 2019.03.14 Seoul, Korea

Tabu K and Taga T. A monocyte-recruiting phenotype defines functional heterogeneity of glioma cells with stemness and chemoresistance. The 77th Annual Meeting of the Japanese Cancer Association 2018.09.29 Osaka International Convention Center、Osaka

Tabu K and Taga T. Identification of a subpopulation of glioma cells with a potential for tumor niche development involving myeloid cells. The 16th Stem Cell Research Symposium 2018.06.02 Centennial Hall, Kyushu University, Fukuoka, Japan

Tabu K and Taga T. Abilities of cancer stem cells to organize the self-advantageous microenvironment niche. TMU-TMDU Joint Symposium 2018 2018.03.24 Tokyo Medical and Dental University, Tokyo, Japan

Murota Y, Wenqing GY, Tabu K, and Taga T. Establishment of glioma mouse model by transducing oncogenic H-RasV12 gene into the p53 deficient astrocytes. The 76th Annual Meeting of the Japanese Cancer Association 2017.09.30 Pacifico Yokohama, Yokohama, Japan

Tabu K, Wang W, Murota Y and Taga T. Self-expanding strategies of glioma stem cells that involves macrophages to adapt to iron-deprivation stress. The 76th Annual Meeting of the Japanese Cancer Association 2017.09.28 Pacifico Yokohama, Yokohama, Japan

田賀哲也、椨康一. 神経膠腫癌幹細胞の利己的生存戦略による癌の進展. 第38回日本 炎症・再生医学会 2017.07.18 大阪国際会議場、大阪

Murota Y, Schmidt S, Tabu K, Ito H, Tanaka S, Bradley M and Taga T. Screening for human pancreatic cancer stem cell niche mimicry by using synthetic polymer microarrays. The 15th Stem Cell Research Symposium 2017.05.27 Tokyo University, Tokyo, Japan

Tabu K and Taga T. Self-maintenance strategies of glioma stem cells (GSCs) involving GSC-induced protumoral macrophages. 11th International Symposium of The Institute Network 2017.01.27 Tokushima University, Tokushima, Japan

Tabu K, Wang W, Murota Y and Taga T. Adaptive response of C6 glioma stem cells to iron deprivation through macrophage induction. The 75th Annual Meeting of the Japanese Cancer Association 2016.10.06 Pacifico Yokohama, Yokohama, Japan

Wang W, Tabu K, Hagiya Y, Murota Y, Ogura S and Taga T. Enhancement of 5-aminolevulinic acid-based fluorescence detection of glioma stem cells by chelating iron. The 75th Annual Meeting of the Japanese Cancer Association 2016.10.06 Pacifico Yokohama, Yokohama, Japan

Tabu K, Kokubu Y, Muramatsu N, Nomoto S, Wang W and Taga T. Adaptive response of rat C6 glioma stem cells to iron deprivation by which the development of tumor infiltrating macrophages is induced. The 14th Stem Cell Research Symposium 2016.05.20 Awaji Yumebutai International Conference Center, Awaji, Japan

Wang W, Tabu K, Sugiyama Y, Hagiya Y, Ogura S and Taga T. Resistance of glioma stem cells to 5-aminolevulinic acid (ALA)-based detection due to enhanced metabolic conversion of protoporphyrin IX. The 14th Stem Cell Research Symposium 2016.05.20 Awaji Yumebutai International Conference Center, Awaji, Japan

Murota Y, Tabu K and Taga T. C6 glioma stem cell-derived extracellular vesicles promote the development of macrophages. The 14th Stem Cell Research Symposium 2016.05.20 Awaji Yumebutai International Conference Center, Awaji, Japan

Tabu K, Muramatsu N, and Taga T. Synthetic polymer-based approach revealed an adaptive capacity of glioma stem cells by inducing tumor-infiltrating and iron-accumulating macrophages. The 38th Annual Meeting of the Molecular Biology Society of Japan 2015.12.01 Kobe International Conferance Center, Kobe, Japan

Wang W, Tabu K, KokubuY, Hagiya Y, Ogura S, and Taga T. Splenic abnormal erythropoiesis in C6 glioma-bearing mice: an implication for their environment of cancer stem cells. The 74th Annual Meeting of the Japanese Cancer Association 2015.10.08 Nagoya Congress Center, Nagoya, Japan

Taga T and Tabu K. Characterization of C6 glioma cancer stem cells and their niche. Seoul National University, Cancer Research Institute (SNU CRI) Annual Symposium 2015 ‘Innovative Approaches to Explore Novel Druggable Targets’ 2015.04.01 Hwasun, Korea